Major Portfolio Boost
True North Advisors significantly expands Q1 portfolio with major increases in tech, ETFs
Anonymous
Key Points
1
ANET: True North added 7,978 shares in Arista Networks during Q1, bringing its total stake to 11,797 shares with the position valued at about $1.448 million at period end.
2
VEA: True North acquired 111,831 additional shares for a total of 286,089, making Vanguard FTSE Developed Markets ETF about 2.1% of its holdings and ranking as the 12th largest position, with a reported value around $18.333 million.
3
AVDS: True North increased its Avantis International Small Cap Equity ETF position by 406,015 shares to 409,040 total, representing about 3.4% of its holdings and ranking as its 5th largest position, with the stake valued at roughly $29.39 million.
4
FLXR: True North raised its TCW Flexible Income ETF stake by 151,556 shares to 508,913, which accounts for about 2.3% of its portfolio and positions FLXR as its 11th largest holding, valued at about $19.99 million.
5
IDXX: True North opened a new position in IDEXX Laboratories with 1,411 shares worth approximately $793,000, and IDEXX has substantial institutional ownership (about 87.84% of its stock held by institutions).
True North Advisors LLC made sweeping portfolio moves in Q1, adding to positions across tech, international equities, and fixed income, according to Watchlist News. The most dramatic shift: a 13,422% surge in its Avantis International Small Cap Equity ETF stake, jumping from near zero to 409,040 shares worth roughly $29.39 million.
The Dallas-based advisory firm also opened a fresh position in IDEXX Laboratories and added millions to its Arista Networks stake. Taken together, the moves signal a broad push into international markets, ETFs, and selective equity bets.
Avantis and VEA Anchor a Big International Bet
The standout move was in Avantis International Small Cap Equity ETF (AVDS). True North added 406,015 shares in a single quarter, bringing its total to 409,040, according to Watchlist News. That makes AVDS the firm's 5th largest holding — about 3.4% of its entire portfolio.
True North also added 111,831 shares of Vanguard FTSE Developed Markets ETF (VEA), lifting its stake to 286,089 shares valued at about $18.33 million. That 64.2% increase makes VEA the firm's 12th largest holding at 2.1% of its portfolio. Both moves point to a clear tilt toward international developed-market exposure.
Fixed Income Gets a Bigger Slice of the Portfolio
True North added 151,556 shares of TCW Flexible Income ETF (FLXR), bringing its total to 508,913 shares worth about $19.99 million, per Watchlist News. FLXR now ranks as the firm's 11th largest position at 2.3% of its holdings. The addition signals a deliberate move toward bonds and flexible income strategies.
The firm also bought a $4.23 million stake in Vanguard Long-Term Treasury ETF (VGLT) during Q1, according to Watchlist News. Long-term Treasury ETFs hold U.S. government bonds that mature in 10 years or more. Buying them suggests True North is hedging against equity risk or expecting interest rates to fall.
Arista Networks Position More Than Triples in One Quarter
True North added 7,978 shares of Arista Networks (ANET) in Q1, a 208.9% increase, per Watchlist News. Its total stake is now 11,797 shares valued at about $1.45 million. Arista makes high-speed networking gear used in data centers — a sector that has seen strong demand tied to AI infrastructure buildout.
The firm also boosted its Vanguard Dividend Appreciation ETF (VIG) stake by 275.6%, now owning 5,401 shares, according to Ticker Report. The fund focuses on companies with a long track record of growing dividends — a defensive play that balances out the firm's more aggressive international ETF bets.
New IDEXX Position Adds Veterinary Diagnostics to the Mix
True North opened a brand-new position in IDEXX Laboratories (IDXX), buying 1,411 shares worth about $793,000, according to Watchlist News. IDEXX makes diagnostic tools and software for veterinary clinics. It is a niche but high-growth segment of the healthcare sector.
Institutions already own about 87.84% of IDEXX's stock, showing strong conviction from professional investors. True North's entry puts it alongside a deep bench of institutional owners. The move adds healthcare-adjacent diversification to a portfolio that leaned heavily on ETFs this quarter.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
21
Articles
10
Reach
31
A
AnonymousAuthor